Indolequinone antitumor agents: Relationship between quinone structure and rate of metabolism by recombinant human NQO1
- 1 March 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (5) , 545-548
- https://doi.org/10.1016/s0960-894x(98)00069-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Role of NAD(P)H:Quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrinBiochemical Pharmacology, 1996
- Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxiaEuropean Journal Of Cancer, 1994
- Cyclopropamitosenes, Novel Bioreductive Anticancer Agents. Synthesis, Electrochemistry, and Biological Activity of 7-Substituted Cyclopropamitosenes and Related IndolequinonesJournal of Medicinal Chemistry, 1994
- CyclopropamitosenesAnti-Cancer Drugs, 1994
- Cyclopropamitosenes, novel bioreductive anticancer agents. Synthesis of 7-methoxycyclopropamitosene and related indolequinonesTetrahedron, 1994
- DT-diaphorase in activation and detoxification of quinonesCancer and Metastasis Reviews, 1993
- The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?Biochemical Pharmacology, 1992
- The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09Cancer Communications, 1991
- [30] DT-diaphorase: Purification, properties, and functionPublished by Elsevier ,1990
- [56] DT diaphorasePublished by Elsevier ,1967